Abstract: This disclosure is directed, at least in part, to AMPK activators useful for the treatment of conditions or disorders associated with AMPK. In some embodiments, the condition or disorder is associated with the gut-brain axis. In some embodiments, condition or disorder is associated with systemic infection and inflammation from having a leaky gut barrier. In some embodiments, the AMPK activators are gut-restricted compounds. In some embodiments, the AMPK activators are agonists or partial agonists.

Abstract: This disclosure is directed, at least in part, to AMPK activators useful for the treatment of conditions or disorders associated with AMPK. In some embodiments, the condition or disorder is associated with the gut-brain axis. In some embodiments, condition or disorder is associated with systemic infection and inflammation from having a leaky gut barrier. In some embodiments, the AMPK activators are gut-restricted compounds. In some embodiments, the AMPK activators are agonists or partial agonists.

Abstract: A method includes receiving a first claim line identifying a first time span and a first quantity of a health care service provided, and a second claim line identifying a second time span and a second quantity of the health care service provided; determining whether the quantity of health care service provided during the first time span exceeds a maximum amount for a predefined time period; generating a payment recommendation for the first claim line; determining whether a beginning date of the second time span is within the predefined time period and, if so, extending the predefined time period past an ending date of the second time span and generating a payment recommendation for the second claim line in response to determining whether the quantity in the first and second claim lines exceeds a maximum amount for the extended time period.

Abstract: This disclosure is directed, at least in part, to AMPK activators useful for the treatment of conditions or disorders associated with AMPK. In some embodiments, the condition or disorder is associated with the gut-brain axis. In some embodiments, condition or disorder is associated with systemic infection and inflammation from having a leaky gut barrier. In some embodiments, the AMPK activators are gut-restricted compounds. In some embodiments, the AMPK activators are agonists or partial agonists.

Abstract: This disclosure is directed, at least in part, to GPCR modulators in combination therapies useful for the treatment of conditions or disorders involving the gut-brain axis. In some embodiments, these modulators are gut-restricted compounds. In some embodiments, these modulators are GPCR agonists, antagonists, inverse agonists, neutral antagonists, positive allosteric modulators, or negative allosteric modulators. In some embodiments, the condition or disorder is a metabolic disorder, such as diabetes or obesity, or a nutritional disorder such as short bowel syndrome.

Abstract: This disclosure is directed, at least in part, to AMPK activators useful for the treatment of conditions or disorders associated with AMPK. In some embodiments, the condition or disorder is associated with the gut-brain axis. In some embodiments, condition or disorder is associated with systemic infection and inflammation from having a leaky gut barrier. In some embodiments, the AMPK activators are gut-restricted compounds. In some embodiments, the AMPK activators are agonists or partial agonists.

Abstract: The present disclosure provides, among other things, component parts that form curable compositions that are useful when forming dry-erase surface coatings and clear dry-erase surface coatings. In some embodiments, when a composition is extended on a substrate and cured, a surface coating or clear surface coating forms that demonstrates at least one dry-erase characteristic. The present disclosure also provides methods of forming and using such compositions.

Abstract: Systems, methods, apparatus, and computer program products are provided for processing claims. In various embodiments, claims can be processed in accordance with a data-driven approach that limits changes to existing claims processing rules by using an inclusions table, an exclusions table, and/or a decision table as part of firing or executing claims processing rules to accommodate for such changes.

Abstract: The present disclosure provides, among other things, component parts that form curable compositions that are useful when forming dry-erase surface coatings and clear dry-erase surface coatings. In some embodiments, when a composition is extended on a substrate and cured, a surface coating or clear surface coating forms that demonstrates at least one dry-erase characteristic. The present disclosure also provides methods of forming and using such compositions.

Abstract: Systems, methods, apparatus, and computer program products are provided for processing claims. In various embodiments, claims can be processed in accordance with a data-driven approach that limits changes to existing claims processing rules by using exclusion tables, inclusion tables, and/or decision tables to change or execute rules in a more efficient manner.

Abstract: Systems, methods, apparatus, and computer program products are provided for processing claims. In various embodiments, claims can be processed in accordance with a data-driven approach that limits changes to existing claims processing rules by using exclusion tables, inclusion tables, and/or decision tables to change or execute rules in a more efficient manner.

Abstract: Systems, methods, apparatus, and computer program products are provided for processing claims. In various embodiments, claims can be processed in accordance with a data-driven approach that limits changes to existing claims processing rules by using an inclusions table, an exclusions table, and/or a decision table as part of firing or executing claims processing rules to accommodate for such changes.

Abstract: An absorbent article is provided for absorbing a liquid, the absorbent article including a chassis including a liner, an outer cover, and an absorbent structure positioned between the liner and the outer cover, the chassis including a front region and a back region, the front region and the back region defining a waist region therebetween. The absorbent article also includes a wetness indicator positioned adjacent the liner or the outer cover, the wetness indicator including a hydrophanous tissue layer having an absorbent-structure-facing side and being in liquid communication with the absorbent structure or the liner, and an indicator material disposed between the absorbent-facing side of the tissue layer and the absorbent structure. The absorbent article can also include a film layer disposed adjacent the tissue layer, and the indicator material can include an active constituent adapted to wick along the tissue layer when the absorbent article is insulted.

Abstract: A disposable absorbent article includes an absorbent chassis and a fastening system that together define a refastenable pant. The refastenable pant includes a pair of elastomeric front side panels extending from the waist opening to each leg opening, a pair of elastomeric back side panels extending from the waist opening to each leg opening, and a pair of refastenable seams extending from the waist opening to each leg opening and positioned between the elastomeric front and back side panels.

Abstract: A disposable absorbent article includes an absorbent chassis and a fastening system that together define a refastenable pant. The refastenable pant includes a pair of elastomeric front side panels extending from the waist opening to each leg opening, a pair of elastomeric back side panels extending from the waist opening to each leg opening, and a pair of refastenable seams extending from the waist opening to each leg opening and positioned between the elastomeric front and back side panels.

Abstract: Methods for forming a translucent window on the inner surface of a liquid impermeable breathable film outer cover of an absorbent product, such as a diaper, for viewing a water dispersible ink to indicate when an insult has occurred are disclosed. Additionally, absorbent products having a translucent window and a water dispersible ink are disclosed.

Abstract: Systems, methods, apparatus, and computer program products are provided for accessing, navigating, and displaying multiple versions of claims in an efficient and customer-friendly manner. In various embodiments, claims can be processed and stored such that they can be displayed via an interface in a graphical format (e.g., textual, circular, hierarchical, etc.).

Abstract: Systems, methods, apparatus, and computer program products are provided for accessing, navigating, and displaying multiple versions of claims in an efficient and customer-friendly manner. In various embodiments, claims can be processed and stored such that they can be displayed via an interface in a graphical format (e.g., textual, circular, hierarchical, etc.).

Abstract: Systems, methods, apparatus, and computer program products are provided for accessing, navigating, and displaying multiple versions of claims in an efficient and customer-friendly manner. In various embodiments, claims can be processed and stored such that they can be displayed via an interface in a graphical format (e.g., textual, circular, hierarchical, etc.).

Abstract: Systems, methods, apparatus, and computer program products are provided for processing claims. In various embodiments, claims can be processed in accordance with a data-driven approach that limits changes to existing claims processing rules.